Tokyo, Japan

Yoshiki Tokutake


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Spotlight on Inventor Yoshiki Tokutake: Pioneering Innovations in Medicinal Compositions

Introduction: Yoshiki Tokutake, a talented inventor based in Tokyo, Japan, has made significant contributions to the field of pharmaceuticals with his groundbreaking patent for Glucopyranosyloxybenzylbenzene derivatives. Working at Kissei Pharmaceutical Co., Ltd., Tokutake has demonstrated a passion for innovation and a commitment to improving medicinal compositions.

Latest Patents: Tokutake holds one patent for Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same, and intermediates for the preparation of the derivatives. This patent showcases his expertise in developing novel compounds that have the potential to revolutionize the pharmaceutical industry.

Career Highlights: Throughout his career, Yoshiki Tokutake has been dedicated to pushing the boundaries of pharmaceutical research and development. His work on benzylphenol derivatives has opened up new possibilities for the treatment of various medical conditions, highlighting his innovative approach to drug discovery.

Collaborations: Tokutake has collaborated with esteemed coworkers such as Hideki Fujikura and Nobuhiko Fushimi, further enhancing the impact of his research and inventions. By working closely with fellow experts in the field, he has been able to leverage collective knowledge and expertise to drive forward advancements in pharmaceutical science.

Conclusion: In conclusion, Yoshiki Tokutake stands as a visionary inventor who continues to inspire with his groundbreaking work in medicinal compositions. His dedication to innovation and collaboration underscores his position as a key figure in the pharmaceutical industry, shaping the future of healthcare with his remarkable inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…